Lorbas, so Forty Seven inc is 48 bucks per share a
Post# of 148183
(Total Views: 397)
Posted On: 02/27/2020 8:12:46 PM
Lorbas, so Forty Seven inc is 48 bucks per share and no rev's ? Their product:
"Our immunotherapy, magrolimab (formerly known as 5F9), is an antibody that is designed to block the CD47 “don’t eat me” signal, restoring the ability of macrophages to attack and destroy cancer.
Preventing cancer from suppressing the innate immune system is an emerging field in oncology, and magrolimab is among the first in a new class of innate immune checkpoint inhibitors. We are investigating magrolimab in multiple Phase 1 and Phase 2 trials in various cancers, including non-Hodgkin’s lymphoma, colorectal cancer, ovarian cancer and acute myeloid leukemia as both monotherapy and in combination with approved therapies."
"Our immunotherapy, magrolimab (formerly known as 5F9), is an antibody that is designed to block the CD47 “don’t eat me” signal, restoring the ability of macrophages to attack and destroy cancer.
Preventing cancer from suppressing the innate immune system is an emerging field in oncology, and magrolimab is among the first in a new class of innate immune checkpoint inhibitors. We are investigating magrolimab in multiple Phase 1 and Phase 2 trials in various cancers, including non-Hodgkin’s lymphoma, colorectal cancer, ovarian cancer and acute myeloid leukemia as both monotherapy and in combination with approved therapies."
(0)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼